Müllerian Inhibiting Substance Regulates NFκB Signaling and Growth of Mammary Epithelial Cells in Vivo
Open Access
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (29) , 26799-26806
- https://doi.org/10.1074/jbc.m103092200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated PathwayJournal of Biological Chemistry, 2000
- Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Müllerian Hormone and Its Type II ReceptorJournal of Biological Chemistry, 2000
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFκBFEBS Letters, 1998
- Apoptosis: Activate NF-κB or die?Current Biology, 1997
- Developmental expression of a candidate müllerian inhibiting substance type II receptor.Endocrinology, 1996
- Cellular growth and survival are mediated by β1 integrins in normal human breast epithelium but not in breast carcinomaJournal of Cell Science, 1995
- Human Müllerian inhibiting substance: Enhanced purification imparts biochemical stability and restores antiproliferative effectsProtein Expression and Purification, 1992
- RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangementCell, 1992
- An Immunoassay to Detect Human Mullerian Inhibiting Substance in Males and Females during Normal Development*Journal of Clinical Endocrinology & Metabolism, 1990